Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ceruloplasmin and hephaestin-like 1 pseudogene (CPHL1P) is a processed pseudogene located in the human genome[1][3][4]. Pseudogenes are genetic sequences resembling functional genes but are non-coding due to evolutionary mutations or incomplete sequences. CPHL1P shows high sequence homology to the functional gene for ceruloplasmin, an important multicopper oxidase involved in copper and iron metabolism, and to the gene for hephaestin, which also encodes a multicopper oxidase[3][4][2][5][6]. However, because of deletions, frameshift mutations, and lack of transcription, CPHL1P does not produce a functional protein product[3]. Consequently, it is not relevant as a direct therapeutic, diagnostic, or prognostic target and is primarily of interest in evolutionary and genomic studies. Its parental genes, CP (ceruloplasmin) and HEPH (hephaestin), do play critical roles in diseases of iron and copper metabolism[2][5][6][8], but this function does not extend to CPHL1P itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ceruloplasmin and hephaestin-like 1 pseudogene (CPHL1P).